Next, we set up a novel chronic high insulin-based cellular paradigm to specifically address insulin resistance in cholinergic neurons and found that the IR-IRS-AKT signaling pathway is significantly downregulated in cholinergic neurons (Fig. 3). The gene discussed is INS; the disease is Insulin resistance.